Trump and Bolsonaro discussed research effort on using hydroxychloroquine to fight coronavirus, White House says

FILE PHOTO: The drug hydroxychloroquine, pushed by U.S. President Donald Trump and others in recent months as a possible treatment to people infected with the coronavirus disease (COVID-19), is displayed at the Rock Canyon Pharmacy in Provo, Utah, U.S. May 27, 2020. REUTERS/George Frey/File Photo

WASHINGTON (Reuters) - U.S. President Donald Trump and Brazilian President Jair Bolsonaro discussed a joint research effort on using the anti-malarial drug hydroxychloroquine as both a prophylaxis and treatment for the coronavirus, the White House said on Tuesday.

Trump and Bolsonaro “expressed their mutual appreciation for the longstanding collaboration on health issues between the two countries,” the White House said, discussing the U.S. delivery of 2 million doses of the controversial drug to Brazil and “a joint research effort to help further evaluate the safety and efficacy of hydroxychloroquine for both prophylaxis and the early treatment of the coronavirus.”

Reporting by Lisa Lambert and Jeff Mason; Editing by Chris Reese